Cincinnati Cancer Research Leader Named Woman of the Year
Jill Brinck is honored for her work securing essential seed funding for pediatric oncology research.
Updated on Oct. 22, 2026 in Cancer
Live Poll
Should non-profits, rather than the government, take the lead in funding underfunded medical research?
The Enquirer has named Jill Brinck, executive director of the Cincinnati-based nonprofit CancerFree Kids, as a 2026 Woman of the Year. Brinck has led the organization since 2019, focusing on funding early-stage pediatric cancer research.
Why it matters
Pediatric cancer research frequently faces funding gaps due to limited profitability for drug development. Organizations like CancerFree Kids provide the seed money necessary to generate proof-of-concept data required for larger federal grants.
CancerFree Kids aims for $5 million in annual investments by 2030. This growth goal follows the organization's mission to bridge the funding gap in pediatric oncology where profitability concerns often stifle drug development.
The players
Jill Brinck
Executive director of CancerFree Kids who manages fundraising and organizational expansion for pediatric cancer research.
CancerFree Kids
A Cincinnati-based nonprofit that provides seed funding to early-stage pediatric cancer research projects.
The details
CancerFree Kids operates by providing seed funding to early-stage pediatric cancer research projects. This initial capital allows scientists to develop the essential proof-of-concept data needed to qualify for subsequent federal grants. Since joining in 2019, Brinck has managed the organization's fundraising and expansion efforts, including growth into the Columbus market.
Timeline
2015: Brinck helped deliver a $1 million campaign increase at a previous organization.
2016: Brinck helped deliver a $1 million campaign increase.
2019: Brinck joined CancerFree Kids as executive director.
2026: The Enquirer named Brinck a Woman of the Year.
2030: CancerFree Kids aims for $5 million in annual research investments.
Health Landscape
This effort sits within the broader pediatric oncology funding landscape, where nonprofit seed money serves as a vital precursor to major institutional grants. It follows the pattern set by the National Cancer Institute's pediatric cancer research portfolio in prioritizing underfunded disease areas.
For families navigating childhood cancer, this work underscores the importance of the early research phases in bringing new therapies to clinical trials. Patients interested in how such funding affects access to novel treatments should discuss current clinical trial opportunities with their oncology team.
The takeaway
Nonprofit seed funding plays a critical role in moving pediatric cancer research from the lab to federal grant consideration. Families concerned about treatment options can monitor progress on childhood cancer initiatives through their primary oncology care providers.
Further reading
Learn more about the local landscape of pediatric oncology by visiting the Cancer section.
Source note: This article includes information reported by Cincinnati.
Live Poll
Should non-profits, rather than the government, take the lead in funding underfunded medical research?
